SLV-404

N/A

Report date: 2025/07/03 16:39:02

Base Information

Drug NameSLV-404
Drug Alias NameSLV-404
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Tyrosine-protein kinase transmembrane receptor
TargetsTyrosine-protein kinase transmembrane receptor
Therapy Area/IndicationsRichter's SyndromeLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Turin
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Turin
Inactive CompaniesN/A
Active IndicationsRichter's SyndromeLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A